Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
Status:
Active, not recruiting
Trial end date:
2029-09-01
Target enrollment:
Participant gender:
Summary
Hydroxychloroquine will be administered on an outpatient basis within 12 weeks after primary
surgery followed by adjuvant chemotherapy /or radiation therapy (if needed).
Hydroxychloroquine will be administered orally at a dose of 400 mg daily for 90 days.
Subjects will receive HCQ every day.